A Phase I Dose Escalation Study With Oral LY317615 in Combination With Capecitabine in Advanced Cancer Patients.
Latest Information Update: 05 Aug 2020
At a glance
- Drugs Enzastaurin (Primary) ; Capecitabine
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 30 Sep 2005 New trial record.